Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)
__utmb
Used to distinguish new sessions and visits. This cookie is set when the GA.js javascript library is loaded and there is no existing __utmb cookie. The cookie is updated every time data is sent to the Google Analytics server.
30 minutes after last activity
__utmc
Used only with old Urchin versions of Google Analytics and not with GA.js. Was used to distinguish between new sessions and visits at the end of a session.
End of session (browser)
__utmz
Contains information about the traffic source or campaign that directed user to the website. The cookie is set when the GA.js javascript is loaded and updated when data is sent to the Google Anaytics server
6 months after last activity
__utmv
Contains custom information set by the web developer via the _setCustomVar method in Google Analytics. This cookie is updated every time new data is sent to the Google Analytics server.
2 years after last activity
__utmx
Used to determine whether a user is included in an A / B or Multivariate test.
18 months
_ga
ID used to identify users
2 years
_gali
Used by Google Analytics to determine which links on a page are being clicked
30 seconds
_ga_
ID used to identify users
2 years
_gid
ID used to identify users for 24 hours after last activity
24 hours
_gat
Used to monitor number of Google Analytics server requests when using Google Tag Manager
1 minute
_gac_
Contains information related to marketing campaigns of the user. These are shared with Google AdWords / Google Ads when the Google Ads and Google Analytics accounts are linked together.
90 days
__utma
ID used to identify users and sessions
2 years after last activity
__utmt
Used to monitor number of Google Analytics server requests
10 minutes
Nonalcoholic fatty liver disease (NAFLD) is becoming more common over the world at the same time as diabetes and obesity are becoming more common. Nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) are two types of NAFLD based on liver pathology (NASH). NASH is a clinically advanced type of NAFL that can proceed to cirrhosis and eventually hepatocellular cancer in rare circumstances. In addition to lobular inflammation, it is characterized by fibrosis, hepatocytes with macrovesicular steatosis, and ballooning. Hepatocytes with macrovesicular steatosis but no inflated hepatocytes are classified as NAFL.
To enhance the histological and biochemical characteristics of NAFLD, we examine the role of antioxidants, cytokines, nuclear transcription factor modulation, insulin-sensitizing drugs, lipid modifying agents, gastrointestinal hormones, and antifibrotic therapy. The US Food and Drug Administration (FDA) has not yet approved any medicines or other treatments to prevent or cure NAFLD. Vitamin E (an antioxidant) and pioglitazone are the two best medication alternatives for biopsy-proven NASH, according to the American Association for the Study of Liver Diseases (used to treat diabetes).